Cagliari, Italy

Paolo Fadda

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Neuroscienze Pharmaness S.c.a.r.l.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paolo Fadda. Retrieved from https://idiyas.com/inventor/paolo-fadda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paolo Fadda: Innovator in Pharmaceutical Compositions

Introduction

Paolo Fadda is a notable inventor based in Cagliari, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that utilize non-pathogenic bacteria.

Latest Patents

Fadda holds a patent for "Compositions of spores of non-pathogenic bacteria." This patent focuses on liquid-based pharmaceutical, veterinary, and nutraceutical compositions that comprise non-pathogenic sporogenic bacteria. His work in this area highlights the potential benefits of using safe bacterial components in various health-related applications.

Career Highlights

Paolo Fadda is associated with Neuroscienze Pharmaness S.c.a.r.l., where he continues to advance his research and development efforts. His dedication to innovation in the pharmaceutical industry is evident through his patent and ongoing projects.

Collaborations

Fadda collaborates with esteemed colleagues, including Paolo Lazzari and Luca Pani. Their combined expertise contributes to the advancement of their research initiatives and the development of new products.

Conclusion

Paolo Fadda's work exemplifies the intersection of innovation and health, showcasing the importance of non-pathogenic bacteria in pharmaceutical compositions. His contributions are paving the way for future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…